A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months
Clinical trial NCT01000311 · COMPLETED
Trial details
- NCT number
- NCT01000311
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-11-01
- Enrollment
- 529
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.